Amalgamated Bank increased its stake in shares of CIGNA Co. (NYSE:CI) by 5.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 31,488 shares of the health services provider’s stock after purchasing an additional 1,706 shares during the quarter. Amalgamated Bank’s holdings in CIGNA were worth $6,395,000 as of its most recent filing with the SEC.
Other hedge funds also recently bought and sold shares of the company. Stuart Chaussee & Associates Inc. acquired a new stake in shares of CIGNA during the fourth quarter worth approximately $122,000. Horan Capital Advisors LLC. acquired a new stake in shares of CIGNA during the third quarter worth approximately $123,000. Cerebellum GP LLC acquired a new stake in shares of CIGNA during the fourth quarter worth approximately $127,000. Grove Bank & Trust boosted its holdings in shares of CIGNA by 171.9% during the third quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock worth $182,000 after purchasing an additional 617 shares during the period. Finally, Steward Partners Investment Advisory LLC acquired a new stake in shares of CIGNA during the third quarter worth approximately $185,000. Institutional investors and hedge funds own 87.84% of the company’s stock.
In other news, Director Jane E. Md Henney sold 400 shares of CIGNA stock in a transaction that occurred on Friday, January 12th. The shares were sold at an average price of $212.96, for a total value of $85,184.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP John M. Murabito sold 6,099 shares of CIGNA stock in a transaction that occurred on Thursday, January 18th. The shares were sold at an average price of $220.10, for a total transaction of $1,342,389.90. Following the completion of the transaction, the executive vice president now directly owns 68,026 shares in the company, valued at approximately $14,972,522.60. The disclosure for this sale can be found here. In the last three months, insiders sold 40,931 shares of company stock worth $8,568,543. Insiders own 1.30% of the company’s stock.
CIGNA Co. (NYSE:CI) opened at $195.89 on Thursday. The firm has a market cap of $47,788.26, a P/E ratio of 22.44, a P/E/G ratio of 1.18 and a beta of 0.45. The company has a current ratio of 0.37, a quick ratio of 0.39 and a debt-to-equity ratio of 0.38. CIGNA Co. has a 52-week low of $143.85 and a 52-week high of $227.13.
CIGNA (NYSE:CI) last released its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.94 EPS for the quarter, beating the Zacks’ consensus estimate of $1.87 by $0.07. CIGNA had a net margin of 5.38% and a return on equity of 18.84%. The company had revenue of $10.53 billion for the quarter, compared to analyst estimates of $10.28 billion. During the same quarter last year, the firm posted $1.87 earnings per share. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. equities analysts expect that CIGNA Co. will post 12.9 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 10th. Stockholders of record on Monday, March 12th will be given a $0.04 dividend. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.08%. CIGNA’s dividend payout ratio is 0.46%.
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CIGNA Co. (NYSE:CI).
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.